Latest Breaking News On - Molecular insight pharmaceuticals inc - Page 1 : comparemela.com

LIPAC Oncology Announces Appointment of Josh Hamermesh to the Board of Directors Industry Veteran Brings More Than 20 Years of Biotech Leadership Experience News provided by Share this article Share this article MENLO PARK, Calif., May 6, 2021 /PRNewswire/ LIPAC Oncology LLC., a pharmaceutical company utilizing its liposome-bound nano-technology platform to provide precision targeted cancer drugs for the treatment of multiple tumor types, today announced the appointment of Josh Hamermesh as an independent board director. Josh is a noted expert in driving and supporting the growth of innovative companies thanks to his two decades of leadership experience in the biotechnology industry, said Will Robberts, President of LIPAC Oncology. We welcome Josh to the Board and look forward to his insights and contributions around both corporate and business development, strategy and commercialization as we continue to advance our oncology pipeline and build our business.

Sherri spearJosh hamermeshLeo vartorellaMolecular insight pharmaceuticals incHarvard business schoolAmherst collegeCorporate development at pervasis therapeutics incNeurohealing pharmaceuticals incCorporate development at infinity pharmaceuticals incLocust walk partners incGamida cell ltdWill robbertsChief business officerGamida cellSenior vice presidentLocust walk partners